CGC
Price
$1.01
Change
-$0.00 (-0.00%)
Updated
Nov 21, 11:03 AM (EDT)
Capitalization
350.87M
77 days until earnings call
Intraday BUY SELL Signals
RMTI
Price
$0.86
Change
-$0.00 (-0.00%)
Updated
Nov 20 closing price
Capitalization
33.93M
125 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CGC vs RMTI

Header iconCGC vs RMTI Comparison
Open Charts CGC vs RMTIBanner chart's image
Canopy Growth
Price$1.01
Change-$0.00 (-0.00%)
Volume$132.76K
Capitalization350.87M
Rockwell Medical
Price$0.86
Change-$0.00 (-0.00%)
Volume$240.06K
Capitalization33.93M
CGC vs RMTI Comparison Chart in %
CGC
Daily Signal:
Gain/Loss:
RMTI
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CGC vs. RMTI commentary
Nov 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGC is a Hold and RMTI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 21, 2025
Stock price -- (CGC: $1.01 vs. RMTI: $0.86)
Brand notoriety: CGC: Notable vs. RMTI: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CGC: 125% vs. RMTI: 35%
Market capitalization -- CGC: $350.87M vs. RMTI: $33.93M
CGC [@Pharmaceuticals: Generic] is valued at $350.87M. RMTI’s [@Pharmaceuticals: Generic] market capitalization is $33.93M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGC’s FA Score shows that 0 FA rating(s) are green whileRMTI’s FA Score has 0 green FA rating(s).

  • CGC’s FA Score: 0 green, 5 red.
  • RMTI’s FA Score: 0 green, 5 red.
According to our system of comparison, RMTI is a better buy in the long-term than CGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGC’s TA Score shows that 4 TA indicator(s) are bullish while RMTI’s TA Score has 4 bullish TA indicator(s).

  • CGC’s TA Score: 4 bullish, 6 bearish.
  • RMTI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, RMTI is a better buy in the short-term than CGC.

Price Growth

CGC (@Pharmaceuticals: Generic) experienced а -8.18% price change this week, while RMTI (@Pharmaceuticals: Generic) price change was -5.63% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -3.32%. For the same industry, the average monthly price growth was -7.06%, and the average quarterly price growth was +26.87%.

Reported Earning Dates

CGC is expected to report earnings on Feb 06, 2026.

RMTI is expected to report earnings on Mar 26, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-3.32% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGC($351M) has a higher market cap than RMTI($33.9M). RMTI YTD gains are higher at: -57.787 vs. CGC (-63.139). RMTI has higher annual earnings (EBITDA): 1.23M vs. CGC (-410.31M). CGC has more cash in the bank: 144M vs. RMTI (18.4M). RMTI has less debt than CGC: RMTI (14M) vs CGC (328M). CGC has higher revenues than RMTI: CGC (275M) vs RMTI (88M).
CGCRMTICGC / RMTI
Capitalization351M33.9M1,035%
EBITDA-410.31M1.23M-33,278%
Gain YTD-63.139-57.787109%
P/E RatioN/AN/A-
Revenue275M88M313%
Total Cash144M18.4M783%
Total Debt328M14M2,343%
FUNDAMENTALS RATINGS
CGC vs RMTI: Fundamental Ratings
CGC
RMTI
OUTLOOK RATING
1..100
5555
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
45
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9790
PRICE GROWTH RATING
1..100
9089
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RMTI's Valuation (45) in the Medical Specialties industry is somewhat better than the same rating for CGC (94) in the Agricultural Commodities Or Milling industry. This means that RMTI’s stock grew somewhat faster than CGC’s over the last 12 months.

RMTI's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that RMTI’s stock grew similarly to CGC’s over the last 12 months.

RMTI's SMR Rating (90) in the Medical Specialties industry is in the same range as CGC (97) in the Agricultural Commodities Or Milling industry. This means that RMTI’s stock grew similarly to CGC’s over the last 12 months.

RMTI's Price Growth Rating (89) in the Medical Specialties industry is in the same range as CGC (90) in the Agricultural Commodities Or Milling industry. This means that RMTI’s stock grew similarly to CGC’s over the last 12 months.

RMTI's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that RMTI’s stock grew similarly to CGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGCRMTI
RSI
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 12 days ago
79%
Bullish Trend 29 days ago
86%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
87%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
CGC
Daily Signal:
Gain/Loss:
RMTI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNZUF0.420.04
+9.69%
Guangzhou Automobile Group Co., Ltd.
LMSQF0.150.01
+4.80%
Latin Metals Inc.
FKIDX17.04N/A
N/A
Fidelity Diversified Intl K6
NTXVF0.92N/A
N/A
Nexteer Automotive Group Ltd.
JWCTF0.45N/A
N/A
JW CAYMAN THERAPEUTICS CO LTD.